M. Lichinitser

发表

Health-related quality of life in survivors of locally advanced breast cancer: an international randomised controlled phase III trial.

M. Piccart, C. Gotay, A. Bottomley, 2005, The Lancet. Oncology.

Interpretation Dose-intensive treatment only has a temporary effect on HRQOL, thus enabling more research on intensive treatment for patients with locally advanced breast cancer. Health-related quality of life in survivors of locally advanced breast cancer: an international randomised controlled

M. Piccart, C. Gotay, A. Bottomley, 2005 .

Effective Relief of Malignant Ascites in Patients with Advanced Ovarian Cancer by a Trifunctional Anti-EpCAM × Anti-CD3 Antibody: A Phase I/II Study

R. Kimmig, H. Sommer, V. Gorbounova, 2007, Clinical Cancer Research.

AVEREL: a randomized phase III Trial evaluating bevacizumab in combination with docetaxel and trastuzumab as first-line therapy for HER2-positive locally recurrent/metastatic breast cancer.

R. Greil, F. André, V. Semiglazov, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effects of long-term intravenous ibandronate therapy on skeletal-related events, survival, and bone resorption markers in patients with advanced multiple myeloma.

E. Thiel, P. Delmas, A. Sakalová, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Renal Safety of Intravenous Ibandronic Acid in Breast Cancer Patients with Metastatic Bone Disease

N. E. Kushlinsky, M. Lichinitser, N. Lyubimova, 2003, Clinical drug investigation.

Health-related quality of life parameters as prognostic factors in a nonmetastatic breast cancer population: an international multicenter study.

K. Van Steen, M. Piccart, M. Sprangers, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Expression of Flt-1 and Flk-1 Receptors for Vascular Endothelial Growth Factor on Tumor Cells as a New Prognostic Criterion for Locally Advanced Breast Cancer

M. Lichinitser, N. Zhukov, L. Zhukova, 2003, Bulletin of Experimental Biology and Medicine.

Oral ibandronate improves bone pain and preserves quality of life in patients with skeletal metastases due to breast cancer

R. Bell, D. Tripathy, J. Body, 2004, Pain.

Predicting survival with health-related quality of life scores in locally advanced breast cancer: Results from an international randomized controlled trial.

M. Piccart, A. Bottomley, P. Therasse, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical study of combined use of tomudex (raltitrexed) and xeloda (capecitabine) as first-line treatment for patients with metastasizing colorectal cancer

N. Semenov, M. Lichinitser, N. V. Dobrova, 2008, Bulletin of Experimental Biology and Medicine.

Global , multicenter , randomized , phase II trial of gemcitabine and gemcitabine plus AGS-1 C 4 D 4 in patients with previously untreated , metastatic pancreatic cancer †

B. Wolpin, D. Pezet, Y. Ko, 2013 .